Upadacitinib for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs (DMARDs)
SMC
Record ID 32018001089
English
Details
Project Status:
Completed
URL for project:
https://www.scottishmedicines.org.uk/medicines-advice/upadacitinib-rinvoq-full-smc2315/
Year Published:
2021
URL for published report:
https://www.scottishmedicines.org.uk/medicines-advice/upadacitinib-rinvoq-full-smc2315/
English language abstract:
An English language summary is available
Publication Type:
Full HTA
Country:
Scotland, United Kingdom
MeSH Terms
- Arthritis, Rheumatoid
- Antirheumatic Agents
- Janus Kinase Inhibitors
Contact
Organisation Name:
Scottish Medicines Consortium (SMC)
Contact Address:
Delta House | 50 West Nile Street
Contact Name:
Susan Downie
Contact Email:
susan.downie3@nhs.scot
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.